168 related articles for article (PubMed ID: 28808657)
21. ISCOMs: an adjuvant with multiple functions.
Sjölander A; Cox JC; Barr IG
J Leukoc Biol; 1998 Dec; 64(6):713-23. PubMed ID: 9850152
[TBL] [Abstract][Full Text] [Related]
22. Quil A and ISCOMs as adjuvants for midgut membrane antigens of Boophilus microplus.
Jackson LA; Opdebeeck JP
Appl Parasitol; 1994 Jun; 35(2):87-98. PubMed ID: 8087157
[TBL] [Abstract][Full Text] [Related]
23. [Adjuvants--essential components of new generation vaccines].
Dzierzbicka K; Kołodziejczyk AM
Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant effects of saponins on animal immune responses.
Rajput ZI; Hu SH; Xiao CW; Arijo AG
J Zhejiang Univ Sci B; 2007 Mar; 8(3):153-61. PubMed ID: 17323426
[TBL] [Abstract][Full Text] [Related]
25. Liposomes and ISCOMs.
Kersten GF; Crommelin DJ
Vaccine; 2003 Feb; 21(9-10):915-20. PubMed ID: 12547602
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and Protective Activity of a Chimeric Protein Based on the Domain III of the Tick-Borne Encephalitis Virus E Protein and the OmpF Porin of
Sanina N; Chopenko N; Mazeika A; Davydova L; Leonova G; Stenkova A; Uversky VN; Kostetsky E
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274357
[TBL] [Abstract][Full Text] [Related]
27. Immunostimulatory colloidal delivery systems for cancer vaccines.
Saupe A; McBurney W; Rades T; Hook S
Expert Opin Drug Deliv; 2006 May; 3(3):345-54. PubMed ID: 16640495
[TBL] [Abstract][Full Text] [Related]
28. Immunostimulatory complexes containing Eimeria tenella antigens and low toxicity plant saponins induce antibody response and provide protection from challenge in broiler chickens.
Berezin VE; Bogoyavlenskyi AP; Khudiakova SS; Alexuk PG; Omirtaeva ES; Zaitceva IA; Tustikbaeva GB; Barfield RC; Fetterer RH
Vet Parasitol; 2010 Jan; 167(1):28-35. PubMed ID: 19879050
[TBL] [Abstract][Full Text] [Related]
29. On the preparation, microscopic investigation and application of ISCOMs.
Myschik J; Lendemans DG; McBurney WT; Demana PH; Hook S; Rades T
Micron; 2006; 37(8):724-34. PubMed ID: 16750912
[TBL] [Abstract][Full Text] [Related]
30. On the structure of immune-stimulating saponin-lipid complexes (iscoms).
Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ
Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105
[TBL] [Abstract][Full Text] [Related]
31. The impact of size on particulate vaccine adjuvants.
Shah RR; O'Hagan DT; Amiji MM; Brito LA
Nanomedicine (Lond); 2014 Dec; 9(17):2671-81. PubMed ID: 25529570
[TBL] [Abstract][Full Text] [Related]
32. Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant.
Maraskovsky E; Schnurr M; Wilson NS; Robson NC; Boyle J; Drane D
Immunol Cell Biol; 2009 Jul; 87(5):371-6. PubMed ID: 19381160
[TBL] [Abstract][Full Text] [Related]
33. An overview of adjuvant formulations and delivery systems.
García A; De Sanctis JB
APMIS; 2014 Apr; 122(4):257-67. PubMed ID: 23919674
[TBL] [Abstract][Full Text] [Related]
34. Novel colloidal associations of soyasaponins and lipid components (DPPC, cholesterol) as potential adjuvants for vaccines.
de Groot C; Müsken M; Bleckmann M; Ebensen T; Guzmán CA; Müller-Goymann CC
Vaccine; 2019 Aug; 37(35):4975-4986. PubMed ID: 31320217
[TBL] [Abstract][Full Text] [Related]
35. Adjuvanticity and ISCOM formation by structurally diverse saponins.
Bomford R; Stapleton M; Winsor S; Beesley JE; Jessup EA; Price KR; Fenwick GR
Vaccine; 1992; 10(9):572-7. PubMed ID: 1502835
[TBL] [Abstract][Full Text] [Related]
36. Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines.
Sjölander A; Cox JC
Adv Drug Deliv Rev; 1998 Dec; 34(2-3):321-338. PubMed ID: 10837684
[TBL] [Abstract][Full Text] [Related]
37. Impaired immunogenicity of immunostimulating complexes (iscoms) by administration in slow-release formulations.
Johansson M; Ranlund K; Lövgren-Bengtsson K
Microbes Infect; 2000 Jul; 2(9):1003-10. PubMed ID: 10967281
[TBL] [Abstract][Full Text] [Related]
38. [Membranotropic effect of some triterpene glycosides possessing immunostimulating properties].
Lee IA; Popov AM; Kostetskiĭ EIa; Sanina NM; Mazeĭka AN; Boguslavskiĭ VM
Biofizika; 2008; 53(3):462-9. PubMed ID: 18634319
[TBL] [Abstract][Full Text] [Related]
39. Novel adjuvants & delivery vehicles for vaccines development: a road ahead.
Mohan T; Verma P; Rao DN
Indian J Med Res; 2013 Nov; 138(5):779-95. PubMed ID: 24434331
[TBL] [Abstract][Full Text] [Related]
40. Vaccine technologies: From whole organisms to rationally designed protein assemblies.
Karch CP; Burkhard P
Biochem Pharmacol; 2016 Nov; 120():1-14. PubMed ID: 27157411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
